MEI Pharma Revenue vs. Price To Earning

MEIP Stock  USD 2.43  0.03  1.22%   
Based on the key profitability measurements obtained from MEI Pharma's financial statements, MEI Pharma is performing exceptionally good at this time. It has a great odds to showcase excellent profitability results in April. Profitability indicators assess MEI Pharma's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2002-06-30
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
8.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of 03/05/2025, Price To Sales Ratio is likely to drop to 0.32. In addition to that, Days Sales Outstanding is likely to drop to 0.69. At this time, MEI Pharma's Interest Income is relatively stable compared to the past year. As of 03/05/2025, Net Interest Income is likely to grow to about 4 M, while Net Income Per E B T is likely to drop 1.09.
For MEI Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MEI Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MEI Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MEI Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MEI Pharma over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEI Pharma. If investors know MEI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEI Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.73)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.94)
The market value of MEI Pharma is measured differently than its book value, which is the value of MEI that is recorded on the company's balance sheet. Investors also form their own opinion of MEI Pharma's value that differs from its market value or its book value, called intrinsic value, which is MEI Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEI Pharma's market value can be influenced by many factors that don't directly affect MEI Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEI Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEI Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEI Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MEI Pharma Price To Earning vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining MEI Pharma's current stock value. Our valuation model uses many indicators to compare MEI Pharma value to that of its competitors to determine the firm's financial worth.
MEI Pharma is regarded fourth in revenue category among its peers. It is regarded second in price to earning category among its peers . The ratio of Revenue to Price To Earning for MEI Pharma is about  2,155,728 . At this time, MEI Pharma's Total Revenue is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value MEI Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

MEI Revenue vs. Competition

MEI Pharma is regarded fourth in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 515.98 Million. MEI Pharma retains roughly 65.3 Million in revenue claiming about 13% of equities under Health Care industry.

MEI Price To Earning vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

MEI Pharma

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
65.3 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

MEI Pharma

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
30.29 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

MEI Price To Earning Comparison

MEI Pharma is currently under evaluation in price to earning category among its peers.

MEI Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in MEI Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MEI Pharma will eventually generate negative long term returns. The profitability progress is the general direction of MEI Pharma's change in net profit over the period of time. It can combine multiple indicators of MEI Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income13.1 M13.7 M
Income Before Tax16 M16.8 M
Net Income16 M16.8 M
Income Tax Expense8.8 M9.2 M
Total Other Income Expense Net3.7 M4.6 M
Net Income From Continuing Ops16 M16.8 M
Non Operating Income Net Other22 M23.1 M
Net Loss-28.7 M-30.1 M
Interest Income3.8 MM
Net Interest Income3.8 MM
Change To Netincome3.5 M3.7 M
Net Income Per Share 2.40  2.52 
Income Quality(3.26)(3.10)
Net Income Per E B T 1.15  1.09 

MEI Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on MEI Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MEI Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MEI Pharma's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in MEI Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run AI Portfolio Architect Now

   

AI Portfolio Architect

Use AI to generate optimal portfolios and find profitable investment opportunities
All  Next Launch Module

Use Investing Themes to Complement your MEI Pharma position

In addition to having MEI Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electrical Equipment Thematic Idea Now

Electrical Equipment
Electrical Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electrical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electrical Equipment Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.